SS
CBIO

SBI Securities’s Crescent Biopharma CBIO Stock Holding History

SBI Securities’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22K Hold
68
– – ﹤0.01% 2725
2026
Q1 		$1.25K Hold
68
– – ﹤0.01% 2569
2025
Q4 		$806 Hold
68
– – ﹤0.01% 2719
2025
Q3 		$809 Hold
68
– – ﹤0.01% 2784
2025
Q2 		$1.1K Sell
68
-1
-1% -$21 ﹤0.01% 2640
2025
Q1 		$1.46K Hold
69
– – ﹤0.01% 2429
2024
Q4 		$1.73K Buy
+69
New +$1.88K ﹤0.01% 2366

Other funds holding CBIO

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM

SBI Securities's CBIO Position: Q2 2026 in Review

SBI Securities held its Crescent Biopharma (CBIO) position steady in Q2 2026 at 68 shares worth $1.22K. The position accounts for ﹤0.01% of the portfolio, ranked #2725.

SBI Securities first reported a position in CBIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.73K in Q4 2024. 70 funds tracked by Wall St. Rank hold CBIO as of Q2 2026.

  • SBI Securities held 68 shares of Crescent Biopharma worth $1.22K as of Q2 2026.
  • SBI Securities left its Crescent Biopharma share count unchanged in Q2 2026.
  • Crescent Biopharma made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2725 holding.
  • SBI Securities first reported a position in Crescent Biopharma in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Crescent Biopharma position peaked at $1.73K in Q4 2024.
  • 70 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.